Literature DB >> 7236103

Blepharospasm surgery. An anatomical approach.

W N Gillum, R L Anderson.   

Abstract

Essential blepharospasm is an idiopathic, progressively debilitating disease leading to blindness. Years of forceful spasms result in brow ptosis, dermatochalasis, and, frequently, levator aponeurosis and lateral canthal tendon defects. Following standard neurectomy procedures, the facies droop, brow ptosis and dermatochalasis worsen, and ptosis and canthal tendon laxity suddenly become more evident. We describe a procedure involving meticulous extirpation of all accessible orbicularis oculi, procerus, corrugator superciliaris, and facial nerves in postorbicular fascia. This extirpation of eyelid protractors is combined with browplasty with fixation to frontalis and reinforcement of the levator aponeurosis to strengthen the retractors. Our technique opens the eye just as effectively as standard facial neurectomy procedures, simultaneously corrects associated anatomical deformities, and avoids facial paralysis. Gratifying results were obtained in 15 patients followed up for six to 38 months.

Entities:  

Mesh:

Year:  1981        PMID: 7236103     DOI: 10.1001/archopht.1981.03930011056015

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  13 in total

1.  Blepharospasm and Hemifacial Spasm.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-09       Impact factor: 3.598

2.  Clinical outcomes of individualized botulinum neurotoxin type A injection techniques in patients with essential blepharospasm.

Authors:  Youngje Sung; Sang Min Nam; Helen Lew
Journal:  Korean J Ophthalmol       Date:  2015-03-17

3.  Management of blepharospasm.

Authors:  R R Waller; R H Kennedy; J W Henderson; K R Kesty
Journal:  Trans Am Ophthalmol Soc       Date:  1985

Review 4.  Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.

Authors:  S P Kraft; A E Lang
Journal:  CMAJ       Date:  1988-11-01       Impact factor: 8.262

5.  Blepharospasm: a case study comparison of trihexyphenidyl (Artane) versus EMG biofeedback.

Authors:  P J Brantley; C L Carnrike; M E Faulstich; C A Barkemeyer
Journal:  Biofeedback Self Regul       Date:  1985-06

6.  Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections.

Authors:  J S Elston
Journal:  Br J Ophthalmol       Date:  1987-09       Impact factor: 4.638

7.  Surgical management of essential blepharospasm.

Authors:  A K Bates; B L Halliday; C S Bailey; J R Collin; A C Bird
Journal:  Br J Ophthalmol       Date:  1991-08       Impact factor: 4.638

8.  Effect of treatment with botulinum toxin on neurogenic blepharospasm.

Authors:  J S Elston; R W Russell
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-22

9.  Blepharospasm: a review of 264 patients.

Authors:  F Grandas; J Elston; N Quinn; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

10.  Beneficial effect of botulinum A toxin in blepharospasm: 16 months' experience with 16 cases.

Authors:  S Maurri; S Brogelli; G Alfieri; F Barontini
Journal:  Ital J Neurol Sci       Date:  1988-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.